Skip to content

Post intra-alveolar extraction pain control with Bupivacaine and Lidocaine

Post intra-alveolar extraction analgesia of Bupivacaine and Lidocaine: A randomized controlled clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR201812526365048
Enrollment
240
Registered
2018-12-06
Start date
2015-09-08
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaesthesia

Interventions

Lidocaine 2 percent

Sponsors

ADELUSI EMMANUEL ADETOLU
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All dental patients of age 18 years and above who required intra-alveolar tooth extraction and who consented to participate in the study.

Exclusion criteria

Exclusion criteria: Patients who required surgical removal of the tooth/teeth Patients with history of allergy to bupivacaine or lidocaine. Patients with cognitive problems e.g. mental retardation, cerebral palsy. Patients with underlying systemic diseases such as uncontrolled diabetic mellitus, hypertension. Regular smoker (2 or more sticks per day) and regular/heavy alcohol intake (more than three drinks (1065ml) of beer per day or more than seven drinks (4970ml) of beer per week, more than three drinks (444ml) of wine per day or more than seven drinks (1036ml) of wine per week, more than three drinks (132ml) of distilled spirit per day or more than seven drinks (308ml) of distilled spirit per week).139, 140, 141 Patients who were on antibiotics, oral contraceptive, or steroid therapy Patients who could not read and write. Patients with complicated tooth extraction (more than 30minutes) Patients with tooth mobility greater than grade I Patients with dentoalveolar abscess, orofacial cellulitis or abscess Pregnant patients (bupivacaine crosses the placenta barrier to the baby) Patients with known allergy to adrenaline Patients who declined participation in the study

Design outcomes

Primary

MeasureTime frame
post operative pain prevention

Secondary

MeasureTime frame
Prevention of post operative pain

Countries

Nigeria

Contacts

Public ContactEmmanuel Adelusi

Consultant

godwithus73@yahoo.com2348034659807

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026